Your browser doesn't support javascript.
loading
Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
Kamezaki, K; Kikushige, Y; Numata, A; Miyamoto, T; Takase, K; Henzan, H; Aoki, K; Kato, K; Nonami, A; Kamimura, T; Arima, F; Takenaka, K; Harada, N; Fukuda, T; Hayashi, S; Ohno, Y; Eto, T; Harada, M; Nagafuji, K.
Affiliation
  • Kamezaki K; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Bone Marrow Transplant ; 39(9): 523-7, 2007 May.
Article in En | MEDLINE | ID: mdl-17369863
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, B-Cell / Lymphoma, Large B-Cell, Diffuse / Hematopoietic Stem Cell Mobilization / Peripheral Blood Stem Cell Transplantation / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2007 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, B-Cell / Lymphoma, Large B-Cell, Diffuse / Hematopoietic Stem Cell Mobilization / Peripheral Blood Stem Cell Transplantation / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2007 Document type: Article